ICICI Prudential Nifty Pharma Index Fund - Growth vs ICICI Prudential Nifty PSU Bond Plus SDL Sep 2027 40:60 Index Fund - Growth
Side-by-side comparison of NAV, returns, expense ratio and star rating.
TopFund Analysis
ICICI Prudential Nifty Pharma Index Fund - Growth shows stronger performance metrics with a 1-year return of 24.16% and a 3-year CAGR of 20.83%, compared to ICICI Prudential Nifty PSU Bond Plus SDL Sep 2027 40:60 Index Fund - Growth, which has a 1-year return of 5.21% and a 3-year CAGR of 7.2%. However, the Pharma Index Fund has a higher expense ratio of 0.51% compared to the PSU Bond Index Fund's 0.2%, which could impact net returns over time. Investors should weigh the higher potential returns of the Pharma Index Fund against its higher costs and lower star rating.
ICICI Prudential Nifty Pharma Index Fund - Growth
ICICI Prudential Mutual Fund
★★★★★
Other · Index Funds
ICICI Prudential Nifty PSU Bond Plus SDL Sep 2027 40:60 Index Fund - Growth
ICICI Prudential Mutual Fund
★★★★★
Other · Index Funds
| Metric | ICICI Prudential Nifty... | ICICI Prudential Nifty... |
|---|---|---|
| NAV | ₹21.42 | ₹13.36 |
| Star Rating | ★★ | ★★★★★ |
| Expense Ratio | 0.51% | 0.2% |
| AUM | ₹163 Cr | ₹7,771 Cr |
| 1M Return | +10.68% | +0.47% |
| 3M Return | +7.56% | +0.88% |
| 6M Return | +13.89% | +3.04% |
| 1Y Return | +24.16% | +5.21% |
| 3Y CAGR | +20.83% | +7.2% |
| 5Y CAGR | — | +5.9% |
| Risk Level | — | — |
| Fund Manager | Nishit Patel | Anuj Tagra |